Kyverna Therapeutics to Present at Upcoming Investor Conferences in September
Provided By GlobeNewswire
Last update: Aug 25, 2025
EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced that Warner Biddle, Chief Executive Officer of Kyverna, will present at the following upcoming conferences:
Read more at globenewswire.com
